Europe Molecular weight Marker market is anticipated to grow at 12.23% CAGR from 2019 to 2024 and it is estimated that the Europe market was valued at USD 86.92 million in 2019 and is expected to reach USD 154.76 million by 2024.
A molecular-weight size marker, also known as a protein ladder, DNA ladder, or RNA ladder, is a set of standards that are used to identify the approximate size of a molecule run on a gel during electrophoresis, utilizing the principle that molecular weight is inversely proportional to migration rate through a gel matrix.
An increase in the popularity of personalized medicines for the treatment of chronic diseases and genetic disorders is a major factor contributing toward the growth of the market. Personalized medicines involve the application of molecular weight markers for the study of individual’s genome, genes, and diseases. Thus, growing adoption of personalized medicines along with the escalating focus on molecular biology research is expected to boost the demand for molecular weight marker products. Technological advancement in molecular biology products, such as PCR and NGS coupled with high-quality molecular weight marker is another major factor contributing toward growth. Advancement in recent times in these products has provided provision for a clearer background and sharp bands. Thus, the demand for molecular weight marker products is expected to grow in the near future, which in turn is expected to boost the market growth.
The Europe Molecular weight Marker market is segmented on the basis of Products, Type, End User, and Application. On the basis of product, it is segmented into DNA, RNA, and Protein Ladders. The DNA markers segment was the largest revenue-grossing segment and is projected to grow at significant CAGR during the forecast period. Rising R&D activities related to genomics research boosts the demand for DNA markers for genome mapping. The protein markers segment is expected to witness a lucrative growth during the forecast period, owing to the rise in the application of these products for proteomics study. The researchers and biotechnology companies are focusing on the application of proteomics study for new drug discovery and clinical diagnostics. On the basis of Type, it is segmented into Pre-stained, and Specialty. Pre-stained markers were the highest revenue-generating segment in, due to their large application in genomics and proteomics research. The unstained segment is estimated to witness significant growth in the coming years due to its ability to provide highly accurate molecular weight determinations of the sample over a wide molecular weight range. On the basis of Application, it is segmented into PCR, Western Blotting, and Gel Extraction. Molecular weight marker has applications in nucleic acid and proteomics study. The nucleic acid segment dominated the sector is due to an increasing focus on DNA- and RNA-based research. The growing demand for advanced diagnostics and therapeutics products has led to an increased focus on genomics research. The proteomics application segment is expected to be the fastest-growing segment. Rising application of western blotting and gel extraction for proteomics research including drug discovery and clinical diagnostics drives the growth of the market. On the basis of End User, the market is segmented into Contact Research Organizations (CRO), Pharmaceutical Companies, and Academic Institutes. The academic and research institutes segment accounted for the largest share in terms of revenue due to rising funding for molecular biology research by private and government organizations. There is a growing focus on research based on genomics such as genotyping, cytogenetics, gene expression, epigenetic analysis, and transcriptome analysis, which is boosting the application of molecular weight markers in academic and research institutes. The pharmaceutical and biotechnology companies segment is anticipated to witness significant CAGR over the forecast period due to the rising investment in R&D for new drug development.
On the basis of geography, the market I segmented into various regions namely Germany, Italy, Spain, U.K. and France. Europe accounts for the second largest share of the market due to the presence of highly developed healthcare and research infrastructure in the region. Asia Pacific is estimated to witness the highest CAGR during the forecast period, due to the rising focus of CROs and biotechnology companies in this region for drug discovery and development. Moreover, the CROs are focusing on Asian countries such as China and India for clinical trials owing to less stringent government regulations and availability of skilled professionals is further expected to boost the market growth.
Some of the key players dominating the market are F Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies, Sigma-Aldrich, Affymetrix, Inc., QIAGEN, Takara Bio Inc., Bio-Rad Laboratories, Promega Corporation and New England Biolabs.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 DNA
5.1.3 RNA
5.1.4 Protein Ladders
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Type
5.2.1 Introduction
5.2.2 Pre-stained
5.2.3 Specialty
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Polymerase Chain Reaction (PCR)
5.3.3 Western Blotting
5.3.4 Gel Extraction
5.3.5 Others
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
5.4 End User
5.4.1 Introduction
5.4.2 Academic Institutes
5.4.3 Pharmaceutical Companies
5.4.4 Contract Research Organizations (CRO)
5.4.5 Others
5.4.6 Y-o-Y Growth Analysis, By End User
5.4.7 Market Attractiveness Analysis, By End User
5.4.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By Application
6.1.5.5 By End User
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 F Hoffmann-La Roche AG
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Thermo Fisher Scientific Inc.
8.3 Agilent Technologies
8.4 Sigma-Aldrich
8.5 Affymetrix Inc.
8.6 QIAGEN
8.7 Takara Bio Inc.
8.8 Bio-Rad Laboratories
8.9 Promega Corporation
8.10 New England Biolabs.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Aug 2019
Download Sample
